HER2 Low Breast Neoplasms
1 clinical trials · Condition
◉ Watch HER2 Low Breast Neoplasms
| Record | Firm | Date |
|---|---|---|
| A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors (NCT06157892) | Seagen, a wholly owned subsidiary of Pfizer | 2024-05-20 |
Track HER2 Low Breast Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.